Register Login

Abiopharma

  • Home
  • About
  • Newsroom
  • Company List
  • Events
  • Automated Tools
  • Contact

News list

AstraZeneca (AZN)

  • Event
  • July 05, 2022, 10:11 UTC
  • 17
  • 1 comments

(70% Positive) AstraZeneca (AZN) Announces Clinical Development Update (Form 6-K)

Comment Full text

Autolus Therapeutics plc (AUTL)

  • Event
  • July 01, 2022, 21:15 UTC
  • 17
  • 1 comments

(99% Neutral) Autolus Therapeutics plc (AUTL) Announces 2021 Annual General Meeting

Comment Full text

OptiNose Inc (OPTN)

  • Event
  • July 01, 2022, 20:34 UTC
  • 18
  • 1 comments

(99% Neutral) OPTINOSE, INC. (OPTN) Files Form 8-K

Comment Full text

Century Therapeutics Inc (IPSC)

  • Event
  • July 01, 2022, 20:31 UTC
  • 18
  • 1 comments

(99% Neutral) Century Therapeutics, Inc. (IPSC) Announces Business Combination

Comment Full text

Brooklyn ImmunoTherapeutics Inc (the company was transformed Eterna Therapeutics (ERNA)) (BTX)

  • Event
  • July 01, 2022, 20:30 UTC
  • 18
  • 1 comments

(99% Neutral) Brooklyn ImmunoTherapeutics, Inc. (BTX) Files Form 8-K

Comment Full text

Nektar Therapeutics (NKTR)

  • Event
  • July 01, 2022, 20:15 UTC
  • 18
  • 1 comments

(99% Neutral) NEKTAR THERAPEUTICS (NKTR) Announces New Board Appointment

Comment Full text

Spero Therapeutics Inc (SPRO)

  • Event
  • July 01, 2022, 20:06 UTC
  • 18
  • 1 comments

(99% Neutral) SPERO THERAPEUTICS, INC. (SPRO) Announces Executive Changes

Comment Full text

Genmab (GMAB)

  • Event
  • July 01, 2022, 16:23 UTC
  • 17
  • 1 comments

(99% Neutral) Genmab (GMAB) Announces Clinical Development Update (Form 6-K)

Comment Full text

AstraZeneca (AZN)

  • Event
  • July 01, 2022, 14:00 UTC
  • 19
  • 1 comments

(99% Neutral) AstraZeneca (AZN) Files Form 6-K

Comment Full text

Centessa Pharmaceuticals plc (CNTA)

  • Event
  • July 01, 2022, 12:45 UTC
  • 20
  • 1 comments

(75% Positive) CENTESSA PHARMACEUTICALS PLC (CNTA) Announces Clinical Development Update

Comment Full text
  • Previous
  • 565
  • 566
  • 567
  • 568
  • 569
  • Next

Search

News categories

  • Technical Exchange News(12514)
  • Event(6229)
  • SEC News(284376)
  • FDA Approval(10304)
  • Company Report(721)
  • Business News(162158)
Market reaction

© Copyright Abiopharma. All Rights Reserved
Designed by Alexey Vershinin